Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Spinal cord & DRG stimulation · Alabama | Spinal cord & DRG stimulation · Texas | |
|---|---|---|
| Surgeons, 2024 | 4 | 99 |
| Medicare fee-for-service cases | 201 | 3,368 |
| Growth since 2019 (Medicare FFS) | −12%/yr | +0.4%/yr |
| Forecast cases (Medicare FFS) | 180 in 2030 | 4,030 in 2030 |
| Forecast growth | −1.6%/yr to 2030 | +3.1%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 0.4 | 1.4 |
| Medicare Advantage share | 64% | 59% |
| Out of hospital | 35% (+24 pts since 2019) | 71% (+26 pts since 2019) |
| Cases per surgeon | 50 | 34 |
| Top 10 surgeons' share | 100% | 29% |
| Surgeons growing | 1 | 7 |
| New since the base year | 0 | 10 |
| Likely to stop billing it | 1 by 2026 | 37 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | $34K | $20K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.